• The inflammatory cytokine IL is an additional factor

  2024-04-02

  

  The inflammatory cytokine IL-6 is an additional factor that has been hypothesized to contribute to epinephrine-mediated repression of drug detoxifying proteins such as CYP3A4 (Aninat et al., 2008). Indeed, this CYP is well-known to be repressed by IL-6 (Dickmann et al., 2011) and epinephrine has pre

• br Role of OCT in histamine clearance Histamine is

  2024-04-02

  

  Role of OCT3 in histamine clearance Histamine is a powerful neuromodulator, as well as a regulator of immune processes and vascular tone in the central nervous system (Gross, 1981; Haas et al., 2008; Jutel et al., 2006). In contrast to 5-HT and the catecholamines, a high-affinity transporter for

• Mechanistically NAergic signaling in the

  2024-04-02

  

  Mechanistically, NAergic signaling in the VTA modulates neuronal activity presumably via α1-AR. The majority of α1-ARs are found in the VTA are located presynaptically on unmyelinated dgat1 inhibitor and axon terminals of glutamatergic and GABAergic neurons. However, α1-ARs are also found on neuron

• The results also showed that

  2024-04-02

  

  The results also showed that the A3 receptor agonist increased the phosphorylated levels of Akt, leading to activation of the PI3K/Akt pathway. A3 Chaetocin stimulation has protective effects against RGC death following ischemia-reperfusion, glutamate toxicity, and optic nerve transection models (G

• Introduction Myasthenia gravis MG is an

  2024-04-02

  

  Introduction Myasthenia gravis (MG) is an autoimmune disorder characterized by muscle weakness, which is mainly due to autoantibodies reducing the number or function of postsynaptic AEE788 receptors (AChRs) [1], [2]. Animal models have been developed to uncover the immunopathogenesis of MG. Experi

• In order to increase the oral bioavailability abiraterone is

  2024-04-02

  

  In order to increase the oral bioavailability, abiraterone (157) is being used in the form of its 3β-acetoxy prodrug, abiraterone acetate (156). In spite of the fact that high-fat meals increase the oral atp 4 of abiraterone acetate (156), it is recommended that this drug should be taken on an empt

• The approach of enzymatically converting an

  2024-04-02

  

  The approach of enzymatically converting an analyte and detecting it by the resulting small pH changes near the reduced graphene oxide (rGO) surface has successfully been pursued in case of urea (Piccinini et al., 2017). Furthermore, this work reported that electrostatic layer-by-layer (LbL) assembl

• Lapatinib br Implications for cancer ROS

  2024-04-02

  

  Implications for cancer ROS have a long history of being involved in the development and progression of cancer and increased ROS level is considered as a hallmark of many tumors [76], [77]. Initially, it was thought that ROS would serve as chemical mutagens that would indiscriminately damage cell

• br Conclusion br Acknowledgments and disclosure We

  2024-04-02

  

  Conclusion Acknowledgments and disclosure We thank Ms. Crystal Wylie for her help in the preparation of the manuscript. The development of the database upon which analyses of this study were dependent was supported by PO1 DC 00161 from the National Institute on Deafness and Other Communication

• Recently Kamoshita et al evaluated a

  2024-04-01

  

  Recently, Kamoshita et al. (2016) evaluated a mouse model of retinal neuronal disturbance with the intraperitoneal injection of LPS and found that treatment with AICAR suppressed the reduction of conical function and decreased mRNA levels of TNF-α as well as improved mRNA levels of the mitochondrial

• Previous work established interactions between CRF

  2024-04-01

  

  Previous work established interactions between CRF and KOR systems in regulating attention (39). The CRF antagonist ANT attenuated, but did not completely reverse, the effects of PACAP (.5 µg) and did not have any effects on its own (Table 2). There were no significant differences in performance amo

• Introduction Myasthenia gravis MG is an autoimmune disorder

  2024-04-01

  

  Introduction Myasthenia gravis (MG) is an autoimmune disorder characterized by muscle weakness, which is mainly due to autoantibodies reducing the number or function of postsynaptic MMP-2 Inhibitor I sale receptors (AChRs) [1], [2]. Animal models have been developed to uncover the immunopathogenes

• br AD and COX LOX pharmacology Early studies on the

  2024-04-01

  

  AD and COX/5-LOX pharmacology Early studies on the role of cyclooxygenases in AD were inspired by epidemiological data suggesting that COX inhibitors such as nonsteroidal anti-inflammatory drugs (NSAIDs) could be beneficial in AD patients (Lucca et al., 1994, McGeer et al., 1990). This line of re

• br Autophagy in the central nervous system The autophagic pr

  2024-04-01

  

  Autophagy in the central nervous system The autophagic process appears to be very important for the cells of the central nervous system, as it allows to maintain the functional integrity of the nervous tissue. Indeed macroautophagy is involved in the regulation of homeostasis of the CNS, playing

• Pompe disease is accompanied by the deficiency of

  2024-04-01

  

  Pompe disease is accompanied by the deficiency of the lysosomal α-1,4-glucosidase that makes the Quinidine unable to hydrolyze glycogen to glucose, thereby resulting in the accumulation of glycogen in lysosomes, especially in skeletal muscles and cardiac tissues. This accumulation results in the st

16118 records 195/1075 page Previous Next First page 上5页 191192193194195 下5页 Last page